• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Immunovant Inc (NQ: IMVT )

    31.42 +1.10 (+3.63%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Immunovant Inc

    < Previous 1 2 3 4 5 6 Next >
    Analyst Ratings for Immunovant
    Via Benzinga
    Dow Jones Hits 2023 High, Nasdaq Slips; Tesla Cybertruck, Salesforce In Focus: Weekly Review
    Software earnings were strong, while the Fed is shifting toward rate cuts. 
    Via Investor's Business Daily
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Roivant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class Potential
    From Roivant Sciences
    Via GlobeNewswire
    Where Immunovant Stands With Analysts
    Via Benzinga
    Recap: Immunovant Q2 Earnings
    Via Benzinga
    The Latest Analyst Ratings for Immunovant
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2023
    Via Benzinga
    Lamb Weston, SP Plus And Other Big Stocks Moving Higher On Thursday
    U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Thursday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Stock Market Rally Attempt Underway; Micron, Nike, Amazon, Meta In Focus: Weekly Review
    But it's not a confirmed uptrend yet. Nike, Amazon and Meta were in focus. 
    Via Investor's Business Daily
    Immunovant Inc. (NASDAQ: IMVT) Records 52-Week High Tuesday Morning
    Via Investor Brand Network
    Where Immunovant Stands With Analysts
    Via Benzinga
    What's Going On Pfizer's Subsidiary Biohaven Stock?
    Pfizer Inc's (NYSE: PFE) subsidiary Biohaven Ltd (NYSE: BHVN) released an  
    Via Benzinga
    Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers 
    Via Benzinga
    Biohaven, Yet Another Argenx Rival In Autoimmune Drugs, Just Rocketed 29%
    The companies hope by lowering immunoglobulin G, an antibody, that they can treat myriad autoimmune diseases. 
    Via Investor's Business Daily
    Why Immunovant Stock Is Bolting Higher Today
    The company may have best-in-class autoimmune disease therapy under its roof. 
    Via The Motley Fool
    Immunovant Parlays Its Shot At Rivaling Argenx Into A $300 Million Offering
    Both companies are working on drugs that lower an antibody tied to numerous autoimmune conditions. 
    Via Investor's Business Daily
    Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
    Via Benzinga
    MillerKnoll, Hayward Holdings, Ginkgo Bioworks And Other Big Stocks Moving Higher On Wednesday
    U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 40 points on Wednesday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Roivant Stock Price Outlook: Strong Pipeline Is A Catalyst
    Roivant Sciences has 12 drugs in its pipeline. The company’s Immunovant subsidiary reported strong results for its drug. Roivant is in talks with Roche to sell its Chron’s disease for $7 billion. 
    Via Talk Markets
    Why Shares of Immunovant Are Soaring on Tuesday
    Immunovant sees strong potential for an autoimmune disorder therapy. 
    Via The Motley Fool
    Nasdaq Down 1.5%; Immunovant Shares Spike Higher
    U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 400 points on Tuesday. The Dow traded down 1.19% to 33,601.60 while the NASDAQ fell 1.48% to 13,074.97. The S&P... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi... 
    Via Benzinga
    Crude Oil Moves Higher; Cintas Earnings Top Estimates
    U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Tuesday. The Dow traded down 0.96% to 33,681.79 while the NASDAQ fell 1.24% to 13,106.70. The S&P 500... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
    U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Autoimmune Disease-Focused Immunovant Stock Trading Higher Today?
    Immunovant Inc (NASDAQ: IMVT), a unit of Roivant Sciences Ltd (NASDAQ: ROIV), announced that subcutaneously administered doses of IMVT-1402 produced dose-dependent reductions in Immunoglobulin G (IgG)... 
    Via Benzinga
    These 2 Biotech Stocks Are Bucking a Down Market Tuesday
    Stock index futures pointed to a lower open on Wall Street Tuesday morning. 
    Via The Motley Fool
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Pre-market stock movers are among the biggest topics worth checking out on Tuesday and we have the latest news for investors! 
    Via InvestorPlace
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.